These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 24488757)
1. Expression of stress-induced phosphoprotein1 (STIP1) is associated with tumor progression and poor prognosis in epithelial ovarian cancer. Cho H; Kim S; Shin HY; Chung EJ; Kitano H; Hyon Park J; Park L; Chung JY; Hewitt SM; Kim JH Genes Chromosomes Cancer; 2014 Apr; 53(4):277-88. PubMed ID: 24488757 [TBL] [Abstract][Full Text] [Related]
2. Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer. Huang B; Yin M; Li X; Cao G; Qi J; Lou G; Sheng S; Kou J; Chen K; Yu B Oncotarget; 2016 May; 7(19):27552-66. PubMed ID: 27050277 [TBL] [Abstract][Full Text] [Related]
3. Tumor stress-induced phosphoprotein1 (STIP1) as a prognostic biomarker in ovarian cancer. Chao A; Lai CH; Tsai CL; Hsueh S; Hsueh C; Lin CY; Chou HH; Lin YJ; Chen HW; Chang TC; Wang TH PLoS One; 2013; 8(2):e57084. PubMed ID: 23468915 [TBL] [Abstract][Full Text] [Related]
4. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis. Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer. Qiu JJ; Lin YY; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ Gynecol Oncol; 2014 Jul; 134(1):121-8. PubMed ID: 24662839 [TBL] [Abstract][Full Text] [Related]
6. Expression of 67-kDa laminin receptor was associated with tumor progression and poor prognosis in epithelial ovarian cancer. Song T; Choi CH; Cho YJ; Sung CO; Song SY; Kim TJ; Bae DS; Lee JW; Kim BG Gynecol Oncol; 2012 May; 125(2):427-32. PubMed ID: 22285843 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma. Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423 [TBL] [Abstract][Full Text] [Related]
8. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients. Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906 [TBL] [Abstract][Full Text] [Related]
9. Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer. Ma Z; Wang X; He J; Xia J; Li Y PLoS One; 2017; 12(3):e0174037. PubMed ID: 28355289 [TBL] [Abstract][Full Text] [Related]
10. High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis. Hou M; Cheng Z; Shen H; He S; Li Y; Pan Y; Feng C; Chen X; Zhang Y; Lin M; Wang L; Ke Z Oncotarget; 2015 Nov; 6(34):35813-29. PubMed ID: 26452130 [TBL] [Abstract][Full Text] [Related]
11. MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer. Zhang Y; Zhao FJ; Chen LL; Wang LQ; Nephew KP; Wu YL; Zhang S Oncotarget; 2014 Dec; 5(23):12291-303. PubMed ID: 25460499 [TBL] [Abstract][Full Text] [Related]
12. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer. Ma M; Yu N Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer. Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353 [TBL] [Abstract][Full Text] [Related]
14. Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells. Li H; Cai Q; Godwin AK; Zhang R Mol Cancer Res; 2010 Dec; 8(12):1610-8. PubMed ID: 21115743 [TBL] [Abstract][Full Text] [Related]
15. Dickkopf-4 is frequently overexpressed in epithelial ovarian carcinoma and promotes tumor invasion. Wang S; Wei H; Zhang S BMC Cancer; 2017 Jun; 17(1):455. PubMed ID: 28666421 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma. Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000 [TBL] [Abstract][Full Text] [Related]
17. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer. Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012 [TBL] [Abstract][Full Text] [Related]
18. High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion. Kim HJ; Jeon HK; Cho YJ; Park YA; Choi JJ; Do IG; Song SY; Lee YY; Choi CH; Kim TJ; Bae DS; Lee JW; Kim BG Eur J Cancer; 2012 Aug; 48(12):1914-21. PubMed ID: 22386573 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression. Zhang J; Liu L; Sun Y; Xiang J; Zhou D; Wang L; Xu H; Yang X; Du N; Zhang M; Yan Q; Xi X Oncotarget; 2016 May; 7(18):26516-34. PubMed ID: 27049921 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-137 suppresses tumor growth in epithelial ovarian cancer in vitro and in vivo. Zhang L; Li Z; Gai F; Wang Y Mol Med Rep; 2015 Aug; 12(2):3107-14. PubMed ID: 25955305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]